Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleMolecular Imaging

High-Contrast PET Imaging of Vasopressin V1B Receptors with a Novel Radioligand, 11C-TASP699

Kazumi Koga, Yuji Nagai, Masayuki Hanyu, Mitsukane Yoshinaga, Shigeyuki Chaki, Norikazu Ohtake, Satoshi Ozaki, Ming-Rong Zhang, Tetsuya Suhara and Makoto Higuchi
Journal of Nuclear Medicine October 2017, 58 (10) 1652-1658; DOI: https://doi.org/10.2967/jnumed.116.188698
Kazumi Koga
1National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and
2Taisho Pharmaceutical Co., Ltd., Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuji Nagai
1National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masayuki Hanyu
1National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsukane Yoshinaga
2Taisho Pharmaceutical Co., Ltd., Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeyuki Chaki
2Taisho Pharmaceutical Co., Ltd., Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norikazu Ohtake
2Taisho Pharmaceutical Co., Ltd., Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoshi Ozaki
2Taisho Pharmaceutical Co., Ltd., Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ming-Rong Zhang
1National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuya Suhara
1National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Makoto Higuchi
1National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. 10 1652-1658
DOI 
https://doi.org/10.2967/jnumed.116.188698
PubMed 
28450560

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication December 16, 2016
  • Accepted for publication April 13, 2017
  • Published online October 2, 2017.

Article Versions

  • previous version (April 27, 2017 - 11:47).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Kazumi Koga1,2,
  2. Yuji Nagai1,
  3. Masayuki Hanyu1,
  4. Mitsukane Yoshinaga2,
  5. Shigeyuki Chaki2,
  6. Norikazu Ohtake2,
  7. Satoshi Ozaki2,
  8. Ming-Rong Zhang1,
  9. Tetsuya Suhara1 and
  10. Makoto Higuchi1
  1. 1National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and
  2. 2Taisho Pharmaceutical Co., Ltd., Saitama, Japan
  1. For correspondence or reprints contact: Makoto Higuchi, Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan. E-mail: higuchi.makoto{at}qst.go.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 10 Citations
  • 9 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study
    Makoto Kamiya, Helene D. Sabia, Julie Marella, Maurizio Fava, Charles B. Nemeroff, Hideo Umeuchi, Michihiko Iijima, Shigeyuki Chaki, Izumi Nishino
    Journal of Psychiatric Research 2020 128
  • Vasopressin V1B Receptor Antagonists as Potential Antidepressants
    Shigeyuki Chaki
    International Journal of Neuropsychopharmacology 2021 24 6
  • Oxytocin and vasopressin signaling in health and disease
    Monika Perisic, Katrina Woolcock, Anke Hering, Helen Mendel, Markus Muttenthaler
    Trends in Biochemical Sciences 2024 49 4
  • Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders
    Stephen J Kanes, Lara Dennie, Philip Perera
    Neuropsychiatric Disease and Treatment 2023 Volume 19
  • Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer 11C-TASP699
    Mika Naganawa, Nabeel B. Nabulsi, David Matuskey, Shannan Henry, Jim Ropchan, Shu-Fei Lin, Hong Gao, Richard Pracitto, David Labaree, Ming-Rong Zhang, Tetsuya Suhara, Izumi Nishino, Helene Sabia, Satoshi Ozaki, Yiyun Huang, Richard E. Carson
    Journal of Nuclear Medicine 2022 63 4
  • Prediction of a clinically effective dose of THY1773, a novel V1Breceptor antagonist, based on preclinical data
    Shoko Inatani, Akiko Mizuno‐Yasuhira, Makoto Kamiya, Izumi Nishino, Helene D. Sabia, Hiromi Endo
    Biopharmaceutics & Drug Disposition 2021 42 5
  • The historical progression of positron emission tomography research in neuroendocrinology
    Jason Bini
    Frontiers in Neuroendocrinology 2023 70
  • Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System – V1b-antagonists as a Case in Point
    Florian Holsboer, Marcus Ising
    Pharmacopsychiatry 2024 57 06
  • Cardiac CT, PET & MR
    Nabil E. Boutagy, Attila Feher, Saad Sikanderkhel, Albert J. Sinusas
    2019

Article usage

Article usage: April 2017 to April 2025

AbstractFullPdf
Apr 2017116012
May 2017350043
Jun 201712009
Jul 20175705
Aug 20174709
Sep 20176804
Oct 20177911352
Nov 2017172613
Dec 201787513
Jan 20187817
Feb 20183526
Mar 20183826
Apr 201854711
May 2018261018
Jun 20182376
Jul 20182963
Aug 20181632
Sep 20183016
Oct 20183488
Nov 201815107
Dec 201811308
Jan 2019183714
Feb 201925813
Mar 201913118
Apr 20191348
May 201915510
Jun 20191237
Jul 201924916
Aug 20191069
Sep 20192088
Oct 20191134
Nov 20191918
Dec 20191207
Jan 202036824
Feb 20201414
Mar 202012616
Apr 20201018
May 202014614
Jun 20202917
Jul 2020826
Aug 202016211
Sep 20202484
Oct 20202149
Nov 202020511
Dec 20207106
Jan 20216148
Feb 202181126
Mar 20215137
Apr 202141813
May 20215179
Jun 20215714
Jul 202172423
Aug 202152420
Sep 2021111110
Oct 202131221
Nov 20213931
Dec 202141820
Jan 202241818
Feb 202251511
Mar 20224188
Apr 202231113
May 202201012
Jun 20223810
Jul 20223186
Aug 2022296
Sep 20222916
Oct 202251711
Nov 202231010
Dec 20223117
Jan 2023141710
Feb 202352021
Mar 20233157
Apr 20231145
May 202322013
Jun 20230117
Jul 20232118
Aug 2023649
Sep 2023163
Oct 2023356
Nov 20231086
Dec 20236104
Jan 20241136
Feb 2024147
Mar 20241840
Apr 202452327
May 20243163
Jun 202431310
Jul 202472216
Aug 2024212932
Sep 2024181527
Oct 202451613
Nov 2024584
Dec 202421615
Jan 202501012
Feb 202531610
Mar 202531919
Apr 202563015
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (10)
Journal of Nuclear Medicine
Vol. 58, Issue 10
October 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High-Contrast PET Imaging of Vasopressin V1B Receptors with a Novel Radioligand, 11C-TASP699
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
High-Contrast PET Imaging of Vasopressin V1B Receptors with a Novel Radioligand, 11C-TASP699
Kazumi Koga, Yuji Nagai, Masayuki Hanyu, Mitsukane Yoshinaga, Shigeyuki Chaki, Norikazu Ohtake, Satoshi Ozaki, Ming-Rong Zhang, Tetsuya Suhara, Makoto Higuchi
Journal of Nuclear Medicine Oct 2017, 58 (10) 1652-1658; DOI: 10.2967/jnumed.116.188698

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
High-Contrast PET Imaging of Vasopressin V1B Receptors with a Novel Radioligand, 11C-TASP699
Kazumi Koga, Yuji Nagai, Masayuki Hanyu, Mitsukane Yoshinaga, Shigeyuki Chaki, Norikazu Ohtake, Satoshi Ozaki, Ming-Rong Zhang, Tetsuya Suhara, Makoto Higuchi
Journal of Nuclear Medicine Oct 2017, 58 (10) 1652-1658; DOI: 10.2967/jnumed.116.188698
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer 11C-TASP699
  • Google Scholar

More in this TOC Section

Molecular Imaging

  • Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
  • Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury
  • Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44
Show more Molecular Imaging

Basic

  • Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
  • Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury
  • Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44
Show more Basic

Similar Articles

Keywords

  • vasopressin
  • V1B receptor
  • pituitary
  • Positron Emission Tomography
SNMMI

© 2025 SNMMI

Powered by HighWire